In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation
Journal of Experimental Medicine · 02.03.2026 · 223 (3)
DOI: 10.1084/jem.20250594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 28.01.2026. Verfasst von Lesly Calderón und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Molecular Pathology (IMP), Vienna BioCenter , Vienna, Austria. Hauptthemen laut MEDLINE: Cell Differentiation, Plasma Cells, Lymphocyte Activation, B-Lymphocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, European Research Council, Human Frontier Science Program.
Abstract (Originalsprache)
Immune responses to pathogens lead to the generation of plasma cells through a complex interplay of B cells with their microenvironment in lymphoid organs. To identify new regulators of B cell activation and plasmablast differentiation in the context of the splenic microenvironment, we established an in vivo system for pooled sgRNA CRISPR/Cas9 screens in immunized mice. To improve the infection efficiency of naïve B cells, we generated Cd23-Cre Rosa26LSL-EcoR/+ mice exhibiting increased expression of the ecotropic lentivirus receptor EcoR on naïve B cells. Upon adoptive B cell transfer and immunization of recipient mice, 379 sgRNAs, targeting genes with high expression in plasma cells, were analyzed for their effects on plasmablast generation. Gene hits, encoding 23 positive and 18 negative regulators of B cell activation, plasmablast differentiation, or homeostasis, were uniquely identified in these in vivo screens. Validated genes encoded proteins involved in cell adhesion, signal transduction, protein folding, iron transport, and enzymatic processes. Hence, our in vivo screening system identified novel regulators controlling B cell–mediated immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Research Institute of Molecular Pathology (IMP), Vienna BioCenter , Vienna, Austria.
- Institute of Allergy Research (IAF), Helmholtz Munich and Center of Allergy and Environment (ZAUM), Technical University of Munich , München, Germany.
- Helmholtz Graduate School Environmental Health (HELENA) , Munich, Germany.
ORCID-Profile: Lesly Calderón, Markus Schäfer, Marina Rončević, René Rauschmeier, Markus Jaritz, Tanja A Schwickert, Qiong Sun, Andrea Pauli, Johannes Zuber, Meinrad Busslinger
Förderung
- Boehringer Ingelheim
- European Research Council
- Human Frontier Science Program
Zitieren
APA
Calderón, L., Schäfer, M., Rončević, M., Rauschmeier, R., Jaritz, M., Schwickert, T. A., Sun, Q., Pauli, A., Zuber, J., & Busslinger, M. (2026). In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation. Journal of Experimental Medicine, 223(3). https://doi.org/10.1084/jem.20250594
Vancouver
Calderón L, Schäfer M, Rončević M, Rauschmeier R, Jaritz M, Schwickert TA, et al. In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation. Journal of Experimental Medicine. 2026;223(3). doi:10.1084/jem.20250594
BibTeX
@article{Caldern2026,
author = {Calderón, Lesly and Schäfer, Markus and Rončević, Marina and Rauschmeier, René and Jaritz, Markus and Schwickert, Tanja A and Sun, Qiong and Pauli, Andrea and Zuber, Johannes and Busslinger, Meinrad},
title = {In vivo CRISPR/Cas9 screens identify new regulators of B cell activation and plasma cell differentiation},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {3},
doi = {10.1084/jem.20250594}
}
EUVIMED